Home - Products - MAPK/ERK Signaling - p38 MAPK - methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate( —— )

Catalog No. M24490 CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    517870-17-6
  • Formula Weight
    263.25
  • Molecular Formula
    C13H13NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    COC1=C(C=C(C=C1)C2=CC(=NO2)C(=O)OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TAK-715

    A potent, selective, orally active p38α MAPK inhibitor with IC50 of 7.1 nM.

  • MW-150

    MW-150 (MW01-18-150 SRM) is a novel potent, selective, CNS penetrant and orally active inhibitor of p38α MAPK with Ki of 101 nM.

  • Scio-323

    Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.